¹¹¹Indium (DTPA-octreotide) scintigraphy in patients with cerebral gliomas

Keyphrases

• Somatostatin Receptor Scintigraphy 100%
• Octreotide Scintigraphy 100%
• Cerebral Glioma 100%
• 111Indium 100%
• Somatostatin Receptor 75%
• Glioma Grading 75%
• Tracer Uptake 50%
• Octreotide 50%
• Somatostatin 37%
• Tumor Tissue 25%
• Scintigraphy 25%
• Postoperative Management 25%
• Gold Conjugates 25%
• Tissue Sampling 12%
• Radio 12%
• Tumor Cells 12%
• Cell Surface 12%
• Binding Site 12%
• Human Tumor Cells 12%
• WHO Grade 12%
• Blood-brain Barrier 12%
• Low-grade Tumor 12%
• Preoperative Estimation 12%
• Nineteen 12%
• Pathological Findings 12%
• Tumor Biology 12%
• Tumor Area 12%
• Neuroendocrine Tumor 12%
• Autoradiography 12%
• Tumor Malignancy 12%
• Glioma Patients 12%
• Cerebral Tumor 12%
• Focal Uptake 12%
• Cerebral Abscess 12%
• 99mTc-DTPA 12%
• WHO Grading System 12%
• Somatostatin Analogs 12%
• Normal Brain Tissues 12%

Medicine and Dentistry

• Scintigraphy 100%
• Pentetic Acid 100%
• Ganglioglioma 100%
• Octreotide 100%
• Somatostatin Receptor 100%
• In Vitro 35%
• Neoplasm 28%
• Radioactive Tracer 28%
• Somatostatin 21%
• Conjugate 14%
• Postoperative Management 14%
• Receptor 7%
• Cancer 7%
• Technetium-99 7%
• Brain Tissue 7%
• Tumor Cell 7%
• Cell Surface 7%
• Blood Brain Barrier 7%
• Tumor Biology 7%
• Tumor Cell Culture 7%
• Brain Abscess 7%
• Neuroendocrine Tumor 7%
• Autoradiograph 7%
• Intracranial Tumor 7%
• Somatostatin Derivative 7%
• Binding Site 7%